Table 3. Marmoset details (continued).
ID | Sex | Age | Injection | A/N/B | dMRI | R | V | |
---|---|---|---|---|---|---|---|---|
27 | R01_0075 | F | 5.6Y | A8aV | x | x | ||
28 | R01_0076 | M | 8.9Y | A8aV | x | x | ||
29 | R01_0078 | F | 8.9Y | A13L | x | x | ||
30 | R01_0080 | F | 7.4Y | A9 | x | |||
31 | R01_0081 | F | 7.6Y | A8b | x | x | ||
32 | R01_0083 | F | 6.0Y | A6DR | x | x | ||
33 | R01_0088 | F | 3.7Y | A8aD | x | x | x | x |
34 | R01_0090 | F | 2.9Y | A13M | x | x | x | |
35 | R01_0091 | M | 2.4Y | A8aV | x | x | x | x |
36 | R01_0092 | M | 2.4Y | A24a | x | x | ||
37 | R01_0094 | M | 10.8Y | A9 | x | x | x | x |
38 | R01_0095 | M | 2.3Y | A32 | x | x | ||
39 | R01_0098 | M | 3.3Y | A24b | x | x | x | |
40 | R01_0101 | F | 9.2Y | A8aV | x | |||
41 | R01_0103 | M | 8.2Y | AcbSh | x | x | x | |
42 | R01_0104 | M | 5.3Y | A6Vb | x | x | ||
43 | R01_0107 | M | 2.5Y | A13L | x | x | x | |
44 | R01_0110 | F | 6.7Y | A45 | x | x | ||
45 | R01_0112 | F | 6.0Y | A9 | x | x | x | |
46 | R01_0114 | F | 9.8Y | A25 | x | x | ||
47 | R01_0115 | F | 8.4Y | A32 | x | x | x | |
48 | R04_0023 | M | 2.6Y | A47O | x | x | ||
49 | R04_0058 | F | 5.0Y | A11 | x | x | x | |
50 | R04_0079 | F | 4.3Y | A6M | x | x | ||
51 | R04_0080 | F | 3.2Y | A10 | x | x | x | x |
52 | R04_0095 | F | 2.6Y | A8b | x | x |
“A/N/B” means Anterograde tracer, Nissl and backlit images, “R” means retrograde tracer data and “V” means manual landmark and injection site annotations were generated and were used for validation.
dMRI, diffusion-weighted MRI.